nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—ABCC10—Vincristine—sarcoma	0.242	0.339	CbGbCtD
Cytarabine—ABCC10—Etoposide—sarcoma	0.221	0.31	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—sarcoma	0.151	0.212	CbGbCtD
Cytarabine—CYP3A4—Thiotepa—sarcoma	0.0456	0.0639	CbGbCtD
Cytarabine—CYP3A4—Mitoxantrone—sarcoma	0.0196	0.0275	CbGbCtD
Cytarabine—CYP3A4—Vincristine—sarcoma	0.0135	0.0189	CbGbCtD
Cytarabine—POLB—Base-free sugar-phosphate removal via the single-nucleotide replacement pathway—SMUG1—sarcoma	0.0129	0.142	CbGpPWpGaD
Cytarabine—CYP3A4—Etoposide—sarcoma	0.0124	0.0173	CbGbCtD
Cytarabine—NT5E—periosteum—sarcoma	0.0121	0.0654	CbGeAlD
Cytarabine—POLB—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—sarcoma	0.0112	0.123	CbGpPWpGaD
Cytarabine—NT5E—cartilage tissue—sarcoma	0.00846	0.0458	CbGeAlD
Cytarabine—POLB—Removal of DNA patch containing abasic residue—SMUG1—sarcoma	0.00845	0.0928	CbGpPWpGaD
Cytarabine—CYP3A4—Doxorubicin—sarcoma	0.00843	0.0118	CbGbCtD
Cytarabine—POLB—Base Excision Repair—SMUG1—sarcoma	0.00773	0.0849	CbGpPWpGaD
Cytarabine—DCTD—mammary gland—sarcoma	0.00464	0.0251	CbGeAlD
Cytarabine—Adenosine monophosphate—CREB1—sarcoma	0.00405	0.712	CrCbGaD
Cytarabine—NT5E—mammary gland—sarcoma	0.00359	0.0194	CbGeAlD
Cytarabine—POLE—mammary gland—sarcoma	0.00351	0.019	CbGeAlD
Cytarabine—POLB—hematopoietic system—sarcoma	0.0035	0.019	CbGeAlD
Cytarabine—POLA1—Vinblastine—Vincristine—sarcoma	0.00332	0.624	CbGdCrCtD
Cytarabine—DCTD—myometrium—sarcoma	0.00329	0.0178	CbGeAlD
Cytarabine—POLD1—Removal of DNA patch containing abasic residue—SMUG1—sarcoma	0.00324	0.0356	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00307	0.0337	CbGpPWpGaD
Cytarabine—POLB—skin of body—sarcoma	0.00305	0.0165	CbGeAlD
Cytarabine—POLA1—mammary gland—sarcoma	0.00303	0.0164	CbGeAlD
Cytarabine—DCTD—seminal vesicle—sarcoma	0.00297	0.0161	CbGeAlD
Cytarabine—POLD1—Base Excision Repair—SMUG1—sarcoma	0.00296	0.0325	CbGpPWpGaD
Cytarabine—POLD1—hematopoietic system—sarcoma	0.00286	0.0155	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00285	0.0313	CbGpPWpGaD
Cytarabine—DCTD—hematopoietic system—sarcoma	0.00282	0.0153	CbGeAlD
Cytarabine—CDA—hematopoietic system—sarcoma	0.00257	0.0139	CbGeAlD
Cytarabine—NT5E—myometrium—sarcoma	0.00254	0.0138	CbGeAlD
Cytarabine—POLE—myometrium—sarcoma	0.00249	0.0135	CbGeAlD
Cytarabine—POLD1—skin of body—sarcoma	0.00249	0.0135	CbGeAlD
Cytarabine—DCTD—smooth muscle tissue—sarcoma	0.00249	0.0135	CbGeAlD
Cytarabine—POLB—lymphoid tissue—sarcoma	0.00247	0.0134	CbGeAlD
Cytarabine—NT5E—embryo—sarcoma	0.00245	0.0133	CbGeAlD
Cytarabine—POLE—embryo—sarcoma	0.0024	0.013	CbGeAlD
Cytarabine—POLE—seminal vesicle—sarcoma	0.00225	0.0122	CbGeAlD
Cytarabine—POLB—bone marrow—sarcoma	0.00225	0.0122	CbGeAlD
Cytarabine—NT5E—hematopoietic system—sarcoma	0.00218	0.0118	CbGeAlD
Cytarabine—POLD1—uterus—sarcoma	0.00216	0.0117	CbGeAlD
Cytarabine—POLA1—myometrium—sarcoma	0.00215	0.0116	CbGeAlD
Cytarabine—DCTD—cardiac atrium—sarcoma	0.00214	0.0116	CbGeAlD
Cytarabine—POLE—hematopoietic system—sarcoma	0.00214	0.0116	CbGeAlD
Cytarabine—DCTD—uterus—sarcoma	0.00213	0.0116	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00213	0.0234	CbGpPWpGaD
Cytarabine—NT5E—connective tissue—sarcoma	0.0021	0.0114	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—sarcoma	0.00202	0.0109	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.00201	0.0221	CbGpPWpGaD
Cytarabine—SLC29A1—mammary gland—sarcoma	0.00195	0.0106	CbGeAlD
Cytarabine—POLA1—seminal vesicle—sarcoma	0.00194	0.0105	CbGeAlD
Cytarabine—NT5E—smooth muscle tissue—sarcoma	0.00192	0.0104	CbGeAlD
Cytarabine—POLB—testis—sarcoma	0.00192	0.0104	CbGeAlD
Cytarabine—NT5E—skin of body—sarcoma	0.0019	0.0103	CbGeAlD
Cytarabine—DCTD—tendon—sarcoma	0.00187	0.0101	CbGeAlD
Cytarabine—POLB—DNA Repair—SMUG1—sarcoma	0.00186	0.0204	CbGpPWpGaD
Cytarabine—POLA1—hematopoietic system—sarcoma	0.00184	0.01	CbGeAlD
Cytarabine—POLB—liver—sarcoma	0.00182	0.00984	CbGeAlD
Cytarabine—DCTD—bone marrow—sarcoma	0.00181	0.00981	CbGeAlD
Cytarabine—CDA—lymphoid tissue—sarcoma	0.00181	0.00981	CbGeAlD
Cytarabine—CDA—tendon—sarcoma	0.0017	0.00922	CbGeAlD
Cytarabine—NT5E—cardiac atrium—sarcoma	0.00166	0.00899	CbGeAlD
Cytarabine—NT5E—uterus—sarcoma	0.00165	0.00895	CbGeAlD
Cytarabine—CDA—bone marrow—sarcoma	0.00165	0.00893	CbGeAlD
Cytarabine—Adenosine monophosphate—SRC—sarcoma	0.00164	0.288	CrCbGaD
Cytarabine—POLD1—testis—sarcoma	0.00157	0.0085	CbGeAlD
Cytarabine—DCTD—testis—sarcoma	0.00155	0.00839	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—sarcoma	0.00154	0.00834	CbGeAlD
Cytarabine—POLE—lymphoid tissue—sarcoma	0.00151	0.00817	CbGeAlD
Cytarabine—POLD1—liver—sarcoma	0.00148	0.00804	CbGeAlD
Cytarabine—DCTD—liver—sarcoma	0.00146	0.00793	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—KIT—sarcoma	0.00146	0.0161	CbGpPWpGaD
Cytarabine—NT5E—tendon—sarcoma	0.00145	0.00784	CbGeAlD
Cytarabine—POLE—tendon—sarcoma	0.00142	0.00768	CbGeAlD
Cytarabine—CDA—testis—sarcoma	0.00141	0.00763	CbGeAlD
Cytarabine—NT5E—bone marrow—sarcoma	0.0014	0.00759	CbGeAlD
Cytarabine—POLB—lymph node—sarcoma	0.00139	0.00754	CbGeAlD
Cytarabine—SLC29A1—myometrium—sarcoma	0.00139	0.00752	CbGeAlD
Cytarabine—POLE—bone marrow—sarcoma	0.00137	0.00744	CbGeAlD
Cytarabine—CDA—liver—sarcoma	0.00133	0.00722	CbGeAlD
Cytarabine—DCK—myometrium—sarcoma	0.00132	0.00718	CbGeAlD
Cytarabine—DCK—embryo—sarcoma	0.00127	0.00691	CbGeAlD
Cytarabine—ABCC10—myometrium—sarcoma	0.00126	0.00684	CbGeAlD
Cytarabine—POLA1—tendon—sarcoma	0.00122	0.00662	CbGeAlD
Cytarabine—NT5E—testis—sarcoma	0.0012	0.00649	CbGeAlD
Cytarabine—DCK—seminal vesicle—sarcoma	0.0012	0.00649	CbGeAlD
Cytarabine—SLC29A1—hematopoietic system—sarcoma	0.00119	0.00645	CbGeAlD
Cytarabine—POLA1—bone marrow—sarcoma	0.00118	0.00641	CbGeAlD
Cytarabine—POLD1—Chromosome Maintenance—NPM1—sarcoma	0.00118	0.013	CbGpPWpGaD
Cytarabine—POLE—testis—sarcoma	0.00117	0.00636	CbGeAlD
Cytarabine—SLC29A1—connective tissue—sarcoma	0.00115	0.00621	CbGeAlD
Cytarabine—POLD1—S Phase—STAG1—sarcoma	0.00115	0.0126	CbGpPWpGaD
Cytarabine—ABCC10—seminal vesicle—sarcoma	0.00114	0.00618	CbGeAlD
Cytarabine—POLE—Chromosome Maintenance—NPM1—sarcoma	0.00114	0.0125	CbGpPWpGaD
Cytarabine—DCK—hematopoietic system—sarcoma	0.00114	0.00616	CbGeAlD
Cytarabine—POLD1—lymph node—sarcoma	0.00114	0.00616	CbGeAlD
Cytarabine—NT5E—liver—sarcoma	0.00113	0.00614	CbGeAlD
Cytarabine—DCTD—lymph node—sarcoma	0.00112	0.00608	CbGeAlD
Cytarabine—POLE—liver—sarcoma	0.00111	0.00601	CbGeAlD
Cytarabine—POLE—S Phase—STAG1—sarcoma	0.00111	0.0122	CbGpPWpGaD
Cytarabine—ABCC10—hematopoietic system—sarcoma	0.00108	0.00587	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.00108	0.0118	CbGpPWpGaD
Cytarabine—DCK—Doxorubicin—Epirubicin—sarcoma	0.00104	0.195	CbGdCrCtD
Cytarabine—CDA—lymph node—sarcoma	0.00102	0.00553	CbGeAlD
Cytarabine—POLA1—testis—sarcoma	0.00101	0.00548	CbGeAlD
Cytarabine—DCK—Epirubicin—Doxorubicin—sarcoma	0.000959	0.181	CbGdCrCtD
Cytarabine—POLA1—liver—sarcoma	0.000956	0.00518	CbGeAlD
Cytarabine—SLC29A1—cardiac atrium—sarcoma	0.000904	0.0049	CbGeAlD
Cytarabine—SLC29A1—uterus—sarcoma	0.000899	0.00487	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—VEGFA—sarcoma	0.000875	0.0096	CbGpPWpGaD
Cytarabine—NT5E—lymph node—sarcoma	0.000868	0.0047	CbGeAlD
Cytarabine—DCK—cardiac atrium—sarcoma	0.000864	0.00468	CbGeAlD
Cytarabine—DCK—uterus—sarcoma	0.000859	0.00466	CbGeAlD
Cytarabine—POLE—lymph node—sarcoma	0.00085	0.00461	CbGeAlD
Cytarabine—SLC29A1—lymphoid tissue—sarcoma	0.000838	0.00454	CbGeAlD
Cytarabine—ABCC10—cardiac atrium—sarcoma	0.000823	0.00446	CbGeAlD
Cytarabine—ABCC10—uterus—sarcoma	0.000819	0.00444	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—sarcoma	0.000816	0.00896	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—NPM1—sarcoma	0.000812	0.00891	CbGpPWpGaD
Cytarabine—DCK—lymphoid tissue—sarcoma	0.000801	0.00434	CbGeAlD
Cytarabine—POLA1—S Phase—STAG1—sarcoma	0.000789	0.00866	CbGpPWpGaD
Cytarabine—SLC29A1—tendon—sarcoma	0.000788	0.00427	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000776	0.00852	CbGpPWpGaD
Cytarabine—SLC29A1—bone marrow—sarcoma	0.000763	0.00414	CbGeAlD
Cytarabine—ABCC10—lymphoid tissue—sarcoma	0.000763	0.00414	CbGeAlD
Cytarabine—DCK—tendon—sarcoma	0.000753	0.00408	CbGeAlD
Cytarabine—POLA1—lymph node—sarcoma	0.000733	0.00397	CbGeAlD
Cytarabine—DCK—bone marrow—sarcoma	0.000729	0.00395	CbGeAlD
Cytarabine—ABCC10—tendon—sarcoma	0.000717	0.00389	CbGeAlD
Cytarabine—POLD1—DNA Repair—SMUG1—sarcoma	0.000712	0.00782	CbGpPWpGaD
Cytarabine—ABCC10—bone marrow—sarcoma	0.000695	0.00377	CbGeAlD
Cytarabine—POLE—DNA Repair—SMUG1—sarcoma	0.000687	0.00755	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000678	0.00744	CbGpPWpGaD
Cytarabine—SLC29A1—testis—sarcoma	0.000652	0.00354	CbGeAlD
Cytarabine—DCK—testis—sarcoma	0.000623	0.00338	CbGeAlD
Cytarabine—SLC29A1—liver—sarcoma	0.000617	0.00334	CbGeAlD
Cytarabine—ABCC10—testis—sarcoma	0.000594	0.00322	CbGeAlD
Cytarabine—DCK—liver—sarcoma	0.000589	0.00319	CbGeAlD
Cytarabine—POLE—G1 to S cell cycle control—CREB1—sarcoma	0.000577	0.00634	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—sarcoma	0.000565	0.00621	CbGpPWpGaD
Cytarabine—ABCC10—liver—sarcoma	0.000561	0.00304	CbGeAlD
Cytarabine—POLE—Mitotic M-M/G1 phases—STAG1—sarcoma	0.000504	0.00553	CbGpPWpGaD
Cytarabine—SLC22A1—liver—sarcoma	0.000503	0.00272	CbGeAlD
Cytarabine—POLE—G1 to S cell cycle control—MDM2—sarcoma	0.000478	0.00524	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—sarcoma	0.000473	0.00256	CbGeAlD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00046	0.00505	CbGpPWpGaD
Cytarabine—DCK—lymph node—sarcoma	0.000452	0.00245	CbGeAlD
Cytarabine—CYP3A4—hematopoietic system—sarcoma	0.000442	0.0024	CbGeAlD
Cytarabine—ABCC10—lymph node—sarcoma	0.00043	0.00233	CbGeAlD
Cytarabine—POLE—G1 to S cell cycle control—CCND1—sarcoma	0.000416	0.00457	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000392	0.00431	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—STAG1—sarcoma	0.00039	0.00429	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000382	0.00419	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—STAG1—sarcoma	0.000377	0.00414	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—STAG1—sarcoma	0.000359	0.00394	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—STAG1—sarcoma	0.000349	0.00383	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ENO2—sarcoma	0.000342	0.00375	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000342	0.00375	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—HBA1—sarcoma	0.00034	0.00373	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—STAG1—sarcoma	0.000337	0.0037	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—MYC—sarcoma	0.000334	0.00366	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000333	0.00365	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—NPM1—sarcoma	0.000299	0.00329	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PLCG1—sarcoma	0.00029	0.00319	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—NPM1—sarcoma	0.000289	0.00317	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000279	0.00307	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—sarcoma	0.000274	0.00301	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000274	0.00301	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—STAG1—sarcoma	0.000269	0.00295	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CCND1—sarcoma	0.000268	0.00294	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000267	0.00293	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCND1—sarcoma	0.000259	0.00284	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000244	0.00268	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000243	0.00267	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCND1—sarcoma	0.00024	0.00264	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—STAG1—sarcoma	0.00024	0.00264	CbGpPWpGaD
Cytarabine—CYP3A4—liver—sarcoma	0.000229	0.00124	CbGeAlD
Cytarabine—POLE—G1/S Transition—MYC—sarcoma	0.000229	0.00251	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—sarcoma	0.000225	0.00247	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—MYC—sarcoma	0.000225	0.00247	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—sarcoma	0.000219	0.00241	CbGpPWpGaD
Cytarabine—POLD1—S Phase—MYC—sarcoma	0.000215	0.00236	CbGpPWpGaD
Cytarabine—POLE—S Phase—MYC—sarcoma	0.000208	0.00228	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—NPM1—sarcoma	0.000206	0.00226	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ENO2—sarcoma	0.000196	0.00216	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000195	0.00214	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—HBA1—sarcoma	0.000195	0.00214	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—MYC—sarcoma	0.000193	0.00212	CbGpPWpGaD
Cytarabine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000189	0.00207	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CCND1—sarcoma	0.000185	0.00203	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.00018	0.00198	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ENO2—sarcoma	0.00018	0.00197	CbGpPWpGaD
Cytarabine—CDA—Metabolism—HBA1—sarcoma	0.000178	0.00196	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—sarcoma	0.000171	0.00188	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PLCG1—sarcoma	0.000167	0.00183	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—sarcoma	0.000163	0.00179	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—sarcoma	0.00016	0.00176	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PLCG1—sarcoma	0.000152	0.00167	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000149	0.00164	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—sarcoma	0.000148	0.00163	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—sarcoma	0.000137	0.00151	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.00013	0.00142	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000129	0.00142	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000128	0.00141	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000116	0.00128	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000113	0.00124	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ENO2—sarcoma	0.000111	0.00122	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—HBA1—sarcoma	0.000111	0.00122	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ENO2—sarcoma	0.000105	0.00115	CbGpPWpGaD
Cytarabine—DCK—Metabolism—HBA1—sarcoma	0.000104	0.00114	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000104	0.00114	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000102	0.00112	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.62e-05	0.00106	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PLCG1—sarcoma	9.45e-05	0.00104	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	9.39e-05	0.00103	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MDM2—sarcoma	9.37e-05	0.00103	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—sarcoma	9.13e-05	0.001	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MDM2—sarcoma	9.05e-05	0.000994	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PLCG1—sarcoma	8.89e-05	0.000976	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—sarcoma	8.82e-05	0.000968	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	8.75e-05	0.000961	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.55e-05	0.000939	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	8.47e-05	0.00093	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—sarcoma	8.16e-05	0.000896	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—sarcoma	7.88e-05	0.000866	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	7.77e-05	0.000853	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—sarcoma	7.32e-05	0.000804	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	7.24e-05	0.000795	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—CREB1—sarcoma	7.19e-05	0.00079	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—sarcoma	7.07e-05	0.000776	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—CREB1—sarcoma	6.71e-05	0.000736	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—sarcoma	6.55e-05	0.000719	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MDM2—sarcoma	6.45e-05	0.000708	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—sarcoma	6.32e-05	0.000694	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—sarcoma	6.28e-05	0.00069	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MDM2—sarcoma	5.95e-05	0.000654	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—sarcoma	5.62e-05	0.000617	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MDM2—sarcoma	5.55e-05	0.000609	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—sarcoma	5.38e-05	0.00059	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—sarcoma	5.19e-05	0.00057	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—sarcoma	5.04e-05	0.000553	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—sarcoma	4.5e-05	0.000495	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	4.26e-05	0.000468	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ENO2—sarcoma	4.15e-05	0.000456	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HBA1—sarcoma	4.12e-05	0.000453	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	3.97e-05	0.000436	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ENO2—sarcoma	3.87e-05	0.000425	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HBA1—sarcoma	3.84e-05	0.000422	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—sarcoma	3.7e-05	0.000406	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLCG1—sarcoma	3.52e-05	0.000387	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLCG1—sarcoma	3.28e-05	0.00036	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—sarcoma	3.27e-05	0.000359	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—sarcoma	3.04e-05	0.000334	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ENO2—sarcoma	1.4e-05	0.000153	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HBA1—sarcoma	1.39e-05	0.000152	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLCG1—sarcoma	1.18e-05	0.00013	CbGpPWpGaD
